Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 89

Results For "CAS"

1721 News Found

Vikas Lifecare’s in-house R&D Unit gets DSIR recognition
News | January 17, 2023

Vikas Lifecare’s in-house R&D Unit gets DSIR recognition

This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies


Bhupender Yadav lays foundation stone of 100 bedded ESIC Hospital at Agartala
Healthcare | January 16, 2023

Bhupender Yadav lays foundation stone of 100 bedded ESIC Hospital at Agartala

The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services


India believes in value based health care...: Dr. Mandaviya
Policy | January 14, 2023

India believes in value based health care...: Dr. Mandaviya

Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world


Mastek partners King Faisal Specialist Hospital & Research Centre for healthcare transformation
News | January 13, 2023

Mastek partners King Faisal Specialist Hospital & Research Centre for healthcare transformation

The company was chosen for this transformative exercise due to its deep expertise in the healthcare vertical, coupled with its digital engineering and cloud capabilities, a vast partner network, and long-term relationship with the client


H.B. Fuller to launch new bio-compatible adhesive for medical applications
News | January 12, 2023

H.B. Fuller to launch new bio-compatible adhesive for medical applications

Swiftmelt 1515-I meets performance requirements and secures skin attachment


Merck completes tender offer to acquire Imago BioSciences
News | January 12, 2023

Merck completes tender offer to acquire Imago BioSciences

Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago


Lupin and Exeltis announce reimbursement approval of NaMuscla in Spain
News | January 10, 2023

Lupin and Exeltis announce reimbursement approval of NaMuscla in Spain

NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)


NHA introduces new system to measure hospitals performance empaneled under AB PM-JAY Scheme
Policy | January 10, 2023

NHA introduces new system to measure hospitals performance empaneled under AB PM-JAY Scheme

The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services


Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences
News | January 10, 2023

Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences

In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual